Visiox Pharma names new strategic advisor
17 June 2022 -

Visiox Pharma LLC, a US-based, privately funded biopharmaceutical company, announced on Wednesday that it has appointed Vicente Anido Jr., Ph.D. as its new strategic advisor.

Anido has previously served as chief executive officer at Aerie Pharmaceuticals and at ISTA Pharmaceuticals.

Anido said: "This is an exciting time in eye care to establish a new company that is following in the footsteps of a proven commercial platform. I am eager to help bring two novel drugs to the largest eye care markets inside a year while evaluating additional late-stage products to expand the Visiox pipeline."